Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) CEO Daniel Patrick O’day sold 15,000 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $126.29, for a total value of $1,894,350.00. Following the completion of the sale, the chief executive officer owned 607,133 shares […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) Director Daniel Allen Gold sold 625,783 shares of Roivant Sciences stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $34.00, for a total transaction of $21,276,622.00. Following the transaction, the director directly owned 14,501,546 shares in the […]

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) CEO Eric Venker sold 200,000 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $33.16, for a total transaction of $6,632,000.00. Following the completion of the transaction, the chief executive officer owned 1,613,063 shares of […]